LineaGen
Salt Lake City, US · Delaware corporation · 1 known investors
Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications. The company offers laboratory analysis to identify structural variations and genetic answers for medical and research purposes.
Founders & leadership
GM
Gayland MoffatExecutive
MS
Michael S. PaulExecutive
Board
MF
Michael FitzgeraldBoard director
FA
Fred A. MiddletonBoard director
MC
Mary C. TannerBoard director
MW
Michael WalshBoard director
DK
David KabakoffBoard director
LD
Lisa DunleaBoard director
SM
Stephen M. PrescottBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.2M disclosed across 1 round · 2015
▶$12.2MraisedJan 2015 · 10 investors · Other Health CareRule 506(b)
▶$12.2MraisedJan 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gayland MoffatExecutive Officer
- Michael FitzgeraldDirector
- Michael S. PaulExecutive Officer, Director
- Fred A. MiddletonDirector
- Stephen M. PrescottDirector
- Mary C. TannerDirector
- Michael WalshDirector
- David KabakoffDirector
- Lisa DunleaDirector
- Offering amount
- $12.2M
- Amount sold
- $12.2M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does LineaGen do?
- Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications. The company offers laboratory analysis to identify structural variations and genetic answers for medical and research purposes.
- Who are LineaGen's investors?
- LineaGen's investors include Mountain Group Capital.
- How much funding has LineaGen raised?
- LineaGen has disclosed $12.2M raised across 1 round.
- Where is LineaGen headquartered?
- LineaGen is headquartered in Salt Lake City, US.